{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:01:49Z","timestamp":1791396109956,"version":"4.3.3"},"reference-count":36,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The longitudinal evolution of a myeloma genome from diagnosis to plasma cell leukemia has not previously been reported. We used whole-genome sequencing (WGS) on 4 purified tumor samples and patient germline DNA drawn over a 5-year period in a t(4;14) multiple myeloma patient. Tumor samples were acquired at diagnosis, first relapse, second relapse, and end-stage secondary plasma cell leukemia (sPCL). In addition to the t(4;14), all tumor time points also shared 10 common single-nucleotide variants (SNVs) on WGS comprising shared initiating events. Interestingly, we observed genomic sequence variants that waxed and waned with time in progressive tumors, suggesting the presence of multiple independent, yet related, clones at diagnosis that rose and fell in dominance. Five newly acquired SNVs, including truncating mutations of RB1 and ZKSCAN3, were observed only in the final sPCL sample suggesting leukemic transformation events. This longitudinal WGS characterization of the natural history of a high-risk myeloma patient demonstrated tumor heterogeneity at diagnosis with shifting dominance of tumor clones over time and has also identified potential mutations contributing to myelomagenesis as well as transformation from myeloma to overt extramedullary disease such as sPCL.<\/jats:p>","DOI":"10.1182\/blood-2012-01-405977","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T05:36:22Z","timestamp":1335245782000},"page":"1060-1066","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":354,"title":["Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides"],"prefix":"10.1182","volume":"120","author":[{"given":"Jan B.","family":"Egan","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Xin","family":"Shi","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waibhav","family":"Tembe","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Christoforides","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Kurdoglu","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shripad","family":"Sinari","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Middha","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Asmann","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Braggio","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Keats","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Leif","family":"Bergsagel","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Craig","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Carpten","sequence":"additional","affiliation":[{"name":"Translational Genomics Research Institute, Phoenix, AZ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Keith","family":"Stewart","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"26","key":"2019111807573540300_B1","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1200\/JCO.2005.05.021","article-title":"Molecular pathogenesis and a consequent classification of multiple myeloma.","volume":"23","author":"Bergsagel","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111807573540300_B2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1182\/blood.V98.1.217","article-title":"Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.","volume":"98","author":"Shaughnessy","year":"2001","journal-title":"Blood"},{"issue":"9","key":"2019111807573540300_B3","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V92.9.3025.421k53_3025_3034","article-title":"The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH\/MMSET hybrid transcripts.","volume":"92","author":"Chesi","year":"1998","journal-title":"Blood"},{"issue":"2","key":"2019111807573540300_B4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V88.2.674.bloodjournal882674","article-title":"Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.","volume":"88","author":"Chesi","year":"1996","journal-title":"Blood"},{"issue":"3","key":"2019111807573540300_B5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat Genet"},{"issue":"12","key":"2019111807573540300_B6","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood.V91.12.4457","article-title":"Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.","volume":"91","author":"Chesi","year":"1998","journal-title":"Blood"},{"issue":"3","key":"2019111807573540300_B7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions.","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2019111807573540300_B8","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood.V98.7.2229","article-title":"Hypodiploidy is a major prognostic factor in multiple myeloma.","volume":"98","author":"Smadja","year":"2001","journal-title":"Blood"},{"issue":"11","key":"2019111807573540300_B9","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2002-10-3017","article-title":"Clinical and biologic implications of recurrent genomic aberrations in myeloma.","volume":"101","author":"Fonseca","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2019111807573540300_B10","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-10-1843","article-title":"Genomics in multiple myeloma.","volume":"17","author":"Munshi","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2019111807573540300_B11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2141.1995.tb05365.x","article-title":"High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells.","volume":"91","author":"Juge-Morineau","year":"1995","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111807573540300_B12","first-page":"1280","article-title":"Deletion of the retinoblastoma gene in multiple myeloma.","volume":"8","author":"Dao","year":"1994","journal-title":"Leukemia"},{"issue":"5","key":"2019111807573540300_B13","first-page":"758","article-title":"Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.","volume":"8","author":"Corradini","year":"1994","journal-title":"Leukemia"},{"issue":"2","key":"2019111807573540300_B14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.","volume":"12","author":"Keats","year":"2007","journal-title":"Cancer Cell"},{"issue":"2","key":"2019111807573540300_B15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","article-title":"Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.","volume":"12","author":"Annunziata","year":"2007","journal-title":"Cancer Cell"},{"issue":"5","key":"2019111807573540300_B16","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/leu.2008.4","article-title":"Genetic aberrations and survival in plasma cell leukemia.","volume":"22","author":"Tiedemann","year":"2008","journal-title":"Leukemia"},{"issue":"3","key":"2019111807573540300_B17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.leukres.2005.07.008","article-title":"Analysis of PTEN deletions and mutations in multiple myeloma.","volume":"30","author":"Chang","year":"2006","journal-title":"Leuk Res"},{"issue":"12","key":"2019111807573540300_B18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4065\/mcp.2009.0603","article-title":"Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines.","volume":"84","author":"Kumar","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"7339","key":"2019111807573540300_B19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma.","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"issue":"3","key":"2019111807573540300_B20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12185-009-0288-3","article-title":"Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis.","volume":"89","author":"Jimenez-Zepeda","year":"2009","journal-title":"Int J Hematol"},{"issue":"6","key":"2019111807573540300_B21","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0002-9343(87)90942-9","article-title":"Plasma cell leukemia: an evaluation of response to therapy.","volume":"83","author":"Noel","year":"1987","journal-title":"Am J Med"},{"key":"2019111807573540300_B22","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2019111807573540300_B23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations.","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"issue":"7","key":"2019111807573540300_B24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm.","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat Protoc"},{"issue":"1","key":"2019111807573540300_B25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer.","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2019111807573540300_B26","unstructured":"Gene Expression Omnibus (GEO)\n          Accessed March 26, 2012\n          \n            http:\/\/www.ncbi.nlm.nih.gov\/geo\/"},{"issue":"5","key":"2019111807573540300_B27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","article-title":"Clonal competition with alternating dominance in multiple myeloma.","volume":"120","author":"Keats","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2019111807573540300_B28","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/leu.2009.33","article-title":"New insights to the MLL recombinome of acute leukemias.","volume":"23","author":"Meyer","year":"2009","journal-title":"Leukemia"},{"issue":"1","key":"2019111807573540300_B29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/leu.2010.249","article-title":"The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.","volume":"25","author":"Benedikt","year":"2011","journal-title":"Leukemia"},{"issue":"8","key":"2019111807573540300_B30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations.","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat Methods"},{"issue":"3","key":"2019111807573540300_B31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood.V85.3.650.bloodjournal853650","article-title":"A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells.","volume":"85","author":"Tse","year":"1995","journal-title":"Blood"},{"issue":"5","key":"2019111807573540300_B32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ajh.21396","article-title":"Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics.","volume":"84","author":"Strunk","year":"2009","journal-title":"Am J Hematol"},{"issue":"2","key":"2019111807573540300_B33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccr.2009.12.040","article-title":"A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.","volume":"17","author":"Yokoyama","year":"2010","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111807573540300_B34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/hmg\/ddl444","article-title":"The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.","volume":"16","author":"Bitoun","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"13","key":"2019111807573540300_B35","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2007-05-090514","article-title":"A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.","volume":"110","author":"Mueller","year":"2007","journal-title":"Blood"},{"issue":"11","key":"2019111807573540300_B36","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/onc.2010.515","article-title":"Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.","volume":"30","author":"Yang","year":"2011","journal-title":"Oncogene"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/5\/1060\/1362270\/zh803112001060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/5\/1060\/1362270\/zh803112001060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:12:20Z","timestamp":1574082740000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/5\/1060\/30281\/Wholegenome-sequencing-of-multiple-myeloma-from"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,2]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,8,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-01-405977","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,2]]}}}